Keyphrases
Hyperthermic Isolated Limb Perfusion
100%
Isolated Limb Perfusion
87%
Perfusion
75%
Melanoma Metastasis
62%
Pyogenic Granuloma
50%
Full-thickness Abdominal Wall Defect
50%
Leakage Monitoring
50%
Advanced Melanoma
50%
Negative Pressure Wound Therapy
50%
Split-thickness Skin Graft
50%
Burn Scar
50%
Randomized Controlled Trial
50%
Locally Advanced
50%
Histological Assessment
50%
Radionuclides
50%
Non-ablative Laser
50%
Tumor Response
50%
Successful Treatment
50%
Non-absorbable Mesh
50%
Ablative Fractional Laser Treatment
37%
Local Toxicity
37%
Scar Appearance
37%
Systemic Toxicity
37%
Scar
37%
Partial Response
37%
Complete Response
37%
Mucosa
33%
Wound Rupture
25%
Scar Assessment Scale
25%
Histology
25%
Melphalan
25%
Granuloma Formation
25%
Skin Graft
25%
Early Termination
25%
Abdominal Wall Reconstruction
25%
Gingiva
16%
Papules
16%
Differential Diagnosis
16%
Tumor
16%
Older Adults
16%
Minor Trauma
16%
Bleeding
16%
Polyps
16%
Malignant Tumor
16%
Radionuclide Monitoring
12%
Rate Determination
12%
Repeat Procedure
12%
Erbium Glass Laser
12%
Recurrent Melanoma
12%
In-transit Melanoma
12%
Medicine and Dentistry
Limb Perfusion
100%
Metastatic Melanoma
66%
Negative Pressure Wound Therapy
50%
Randomized Controlled Trial
50%
Skin Transplantation
50%
Low Level Laser Therapy
50%
Radioisotope
50%
Burn Scar
50%
Abdominal Wall Defect
50%
Neoplasm
50%
Nodular Melanoma
50%
Wound Dehiscence
25%
Abdominal Wall
25%
Granulation Tissue
25%
Split Thickness Skin Graft
25%
Melphalan
16%
Recurrent Disease
16%
Adverse Event
12%
Postoperative Period
12%
Patient Satisfaction
12%
Erbium
12%
Erythema
12%
Hyperpigmentation
12%
Technetium-99
10%
Cytotoxic Agent
10%
Radioactive Tracer
10%
Limb
10%
Lower Limb
8%
Upper Limb
8%
Tumor Necrosis Factor
8%
Five-Year Survival Rate
8%
Lymph Node Metastasis
8%
Tumor Regression
8%
Disease
8%
Postoperative Complication
8%
Pharmacology, Toxicology and Pharmaceutical Science
Limb Perfusion
100%
Metastatic Melanoma
66%
Radioisotope
50%
Melanoma
50%
Neoplasm
50%
Recurrent Disease
16%
Melphalan
16%
Cytotoxic Agent
10%
Technetium 99m
10%
Tracer
10%
Tumor Regression
8%
Tumor Necrosis Factor
8%
Disease
8%
Postoperative Complication
8%
Lymph Node Metastasis
8%
Survival Rate
8%
